Dr. Charles Esther Jr, MD

• Pediatric Pulmonology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Nc Hosps, Pediatric Pulmonology University Of Nc Hosps, Pediatrics

  Residency Hospital

• University North Carolina

  Fellowship Hospital, 2004

• Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor, 2021-12-22

• Metabolomics of Airways Disease in Cystic Fibrosis, 2022-05-29

• Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections, 2021-05-14

• Highlights from the 2015 North American Cystic Fibrosis Conference, 2016-04-13

• Accumulation and Persistence of Ivacaftor in Airway Epithelia with Prolonged Treatment, 2020-06-11

• Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections: A preclinical study and randomized controlled trial, 2022-01-31

• Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation, 2016-04-22

• Inverse probability weighted estimation for recurrent events data with missing category, 2021-03-04

• Atopic Asthmatics but not atopics without asthma have enhanced inflammatory response to ozone, 2010-09-07

• Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding, 2018-06-01

• Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study, 2020-12-14

• Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients, 2013-11-09

• Population-level genomics identifies the emergence and global spread of a human transmissible multidrug-resistant nontuberculous mycobacterium, 2016-11-11

• USE OF INHALED IMIPENEM/CILASTATIN IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS: A CASE SERIES, 2019-05-03

• Mapping Targetable Inflammation and Outcomes with Cystic Fibrosis Biomarkers, 2017-07-17

• Airway Epithelial InflammationIn VitroAugments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies Airway Inflammation Augments CFTR Rescue, 2021-03-30

• Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis, 2016-11-11

• Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene, 2021-01-11

• Airway drug pharmacokinetics via analysis of exhaled breath condensate, 2013-08-07

• Semiparametric estimation of the proportional rates model for recurrent events data with missing event category, 2021-06-18

• Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis, 2019-04-03

• Airway purinergic responses in healthy, atopic non-asthmatic, and atopic asthmatic subjects exposed to ozone, 2011-08-31

• Regional Differences in Mucociliary Clearance in the Upper and Lower Airways, 2022-03-09

• Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis, 2019-12-10

• Neutrophilic inflammation is associated with altered airway hydration in stable asthmatics, 2009-07-30